Estimates for quality of life loss due to Respiratory Syncytial Virus.
David HodgsonKatherine E AtkinsMarc BaguelinJasmina Panovska-GriffithsDominic ThorringtonAlbert Jan van HoekHongxin ZhaoEllen B FragaszyAndrew C HaywardRichard PebodyPublished in: Influenza and other respiratory viruses (2019)
Evaluations of potential RSV vaccination programmes should consider their impact across the whole population, not just young child children.